US Patent 11999953 Compositions and methods for treating transposon associated diseases
Article
Patent abstract
The present invention features antisense oligonucleotides (AONs) for the treatment of diseases and disorders associated with the deleterious effects of transposable element insertion (e.g., long interspersed nuclear element-i (LINE-1),